Zydus Group
Edit

Zydus Group

https://zyduscadila.com/
Last activity: 09.04.2024
Categories: ActiveAfricaTechDevelopmentHealthTechMarketMedtechProductProviderResearchWellness
Zydus is an innovation-led global healthcare provider that discovers, manufactures and markets a broad range of healthcare therapies. The group employs over 23,000 people worldwide including over 1400 scientists engaged in research and is dedicated to creating healthier communities globally. With a strong research pipeline of NCEs, biologics and vaccines, the group became India’s first pharmaceutical company to launch its own indigenously researched therapy Lipaglyn which is also the world’s first approved therapy for diabetic dyslipidaemia. Exemptia, the world’s first biosimilar of Adalimumab is also a product of Zydus innovation. Zydus also collaborates with partners to support and make therapies affordable and accessible to communities across the world. As a leading healthcare provider, it aims to become a global research-based pharmaceutical company by 2020. For more details visit www.zyduscadila.com. Official Twitter handle: @ZydusUniverse
Followers
269.13K
Website visits
21.2K /mo.
Mentions
35
Location: India, Gujarat, Ahmedabad
Employees: 10001+
Founded date: 1952

Investors 2

Mentions in press and media 35

DateTitleDescriptionSource
09.04.2024Best of BS Opinion: Buybacks' importance, productive employm...Return on capital and return on liquor policy are what we have today Share buyback is a good way for...business-s...
21.01.2022Cadila Healthcare : Zydus receives final approval from USFDA...www.zyduscadila.com is using a security service for protection against online attacks. This process ...marketscre...
22.12.2021Cadila Healthcare : Zydus Cadila receives tentative approval...Zydus Cadila receives tentative approval from USFDA for Pimavanserin Tablets Ahmedabad, 22 December,...marketscre...
16.12.2021Cadila Healthcare : Zydus receives Orphan Drug Designation f...Zydus receives Orphan Drug Designation from US FDA for ZY-19489, a novel compound to treat malaria Z...marketscre...
10.12.2021Cadila Healthcare : Zydus announces EPICS-IIITM Phase 2(b)/3...www.zyduscadila.com is using a security service for protection against online attacks. This process ...marketscre...
18.11.2021Cadila Healthcare : Zydus Cadila gets 180-day exclusivity fo...www.zyduscadila.com is using a security service for protection against online attacks. This process ...marketscre...
10.11.2021Zydus Cadila receives final approval from USFDA for Glycopyr...Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection Ahmedabad, India, 10 No...marketscre...
22.10.2021Cadila Healthcare : Zydus announces ‘first patient' randomis...www.zyduscadila.com is using a security service for protection against online attacks. This process ...marketscre...
08.10.2021Cadila Healthcare : Zydus Cadila receives tentative approval...www.zyduscadila.com is using a security service for protection against online attacks. This process ...marketscre...
06.10.2021Cadila Healthcare's New Covid-19 Vaccine Gives Booster Shot ...Pankaj Patel, Chairman, Cadila Healthcare Mayur D Bhatt/ Forbes Indiaforbes.com...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In